Phase 2Phase 3RegistrationRecent Approvals Fremanezumab (anti CGRP) for Post-Traumatic Headache Fasinumab1 Chronic lower back pain Laquinimod Huntington disease Fremanezumab (anti CGRP) Cluster Headache Fasinumab1 Osteoarthritis pain Austedo® (SD-809) Tourette syndrome (U.S.) Fremanezumab (anti CGRP) Migraine (U.S & E.U.) ProAir® e-Respiclick® E-connectivity (U.S) CT-P102 (proposed rituximab biosimilar) (U.S.*) CT-P62 (proposed trastuzumab biosimilar)(U.S.*) BENDEKA ®3 CLL and NHL (Selected International Markets) Austedo ® Huntington Disease (U.S.) Austedo ® Tardive dyskinesia(U.S.) Azilect®4 Parkinson’s disease (Japan) ArmonAir ® RespiClick® Asthma (U.S.) AirDuo ® RespiClick® Asthma (U.S.) QVAR® ® (beclomethasone diproprionate BAI) Asthma (U.S.) Reslizumab IV5 Asthma (selected International Markets) Trisenox ® for Acute Promyelocytic Leukemia (U.S.)